바로가기메뉴

본문 바로가기 주메뉴 바로가기

Reference

1.

(2000) Quinupristin-dalfopristin:an overview,

2.

(2003) Linezolid:the first oxazolidinone antimicrobial,

3.

(2005) Daptomycin:a lipopeptide antibiotic for the treatment of serious gram-positive infections,

4.

(2005) Emergence of daptomycin resistance in enterococcus faecium during daptomycin therapy,

5.

(2003) Ramoplanin: a novel antimicrobial agent with the potential to prevent vancomycin-resistant enterococcal infection in high-risk patients,

6.

(2005) Origin, structure, and activity in vitro and in vivo of dalbavancin,

7.

(2004) In vitro activity of tigecycline tested against 11 859 recent clinical isolates associated with community-acquired respiratory tract and gram-positive cutaneous infections,

8.

(2004) Results of a multicenter,randomized,open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients,

9.

(2005) Clinical and bacteriological efficacy of 5-day telithromycin in acute maxillary sinusitis:a pooled analysis,

10.

(2002) Telithromycin is as effective as amoxicillin/clavulanate in acute exacerbations of chronic bronchitis,

11.

(2003) Community-acquired respiratory tract infections caused by resistant pneumococci:clinical and bacteriologic efficacy of the ketolide telithromycin,

12.

(2002) Biapenem,

13.

(2003) Ertapenem,the first of a new group of carbapenems,

14.

(2005) Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis,

15.

(2002) Cerebrospinal fluid penetration and pharmacokinetic/ pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis,

16.

(2004) Successful treatment of Acinetobacter meningitis with intrathecal polymyxin E,

17.

(2003) Voriconazole:a new triazole antifungal agent,

18.

(2003) Echinocandin antifungal drugs,

19.

(2002) Comparison of caspofungin and amphotericin B for invasive candidiasis,

20.

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventinal antifungal therapy,

21.

(2005) Neuraminidase inhibitors for influenza,

Tuberculosis & Respiratory Diseases